ENTPD1 and myeloid sarcoma: Strikingly reduced numbers of CD39+ Tregs -but not of total Tregs- are found in the blood of patients suffering of RR-MS [38], and, more recently, decrease of CD39+ Tregs has been associated to disease progression in HIV [39].